Stefan Gluck, MD: Avastin Improves PFS in HER2-Positive Breast Cancer in AVEREL Study

vitaloptions has 475 videos Subscribe Here

Description: Dr. Stefan Gluck discusses the Avastin (bevacizumab) and how it has been shown to improve progression-free survival in HER2-Positive Breast Cancer in the AVEREL Study presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium.

Dr. Gluck is a Professor of Medicine, University of Miami, Associate Division Chief for Clinical Affaris, Division of Hematology/Oncology Sylvester Comprehensive Cancer Center, University of Miami Health Systems and the Clinical Director, Braman Family Breast Cancer Institute.
Shared By : vitaloptions
Posted on : 01/11/12
Added : 6 years ago
Category : Breast Cancer

More From vitaloptions

Nothing found.